ArticleScientific reports2025
Plant-mediated nickel oxide nanoparticles show species-dependent antibacterial, antioxidant, anti-inflammatory and antidiabetic activities.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synthesis, Characterization, and Multifunctional Bioactivity of ZnO/CuO@Amoxicillin Nanocomposites: A Synergistic Nano-Platform With Potent Antioxidant, Anti-Inflammatory, Antidiabetic, and Anti-Cholinesterase Activities.Chemistry & biodiversity · 2026Article
- Chitosan/β-cyclodextrin nanocarriers enhance 5-fluorouracil efficacy against colorectal cancer via pH-responsive release and apoptosis modulation.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nickel oxide nanoparticles are renowned for their diverse properties, including magnetic, electrical, optical, and catalytic capabilities, making them highly suitable for both industrial and biomedical applications. This study synthesized nickel oxide nanoparticles using both chemical and green synthesis methods with extracts from four plant species: Medicago sativa L., Euphorbia milii Des Moul., Codiaeum variegatum (L.) A. Juss., and Helianthus annuus L. All samples had consistent face-centered cubic structures, as proven by X-ray diffraction. However, electron microscopy and Fourier-transform infrared spectra showed that the green-synthesized particles had tighter size distributions and unique surface functions due to the presence of plant phytochemicals. According to in vitro tests, Codiaeum variegatum mediated nanoparticles showed the strongest multifunctional bioactivity, including increased scavenging of free radicals, targeted cytotoxicity against A549 lung cancer cells, and substantial inhibition of cyclooxygenase-1 and important enzymes that hydrolyze carbohydrates. Antibacterial tests demonstrated that Staphylococcus aureus was efficiently reduced by both chemically produced and Codiaeum variegatum derived nanoparticles, whereas biofilm experiments shown that Medicago sativa derived nanoparticles caused greater disruption. These findings demonstrate that the performance of nanoparticles is controlled by their botanical source, allowing NiO nanoparticles to be tailored for specific medicinal uses. Our results open the door for additional in vivo testing and process optimization while validating green synthesis as an environmentally responsible method of producing NiO nanoparticles with adjustable bioactivities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.